SCHEMBL6949929

SCHEMBL6949929

N#Cc1c(OCCO)nc(CCO)nc1N1CCc2ccccc2CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.38
ALDH1A1 P00352 7/20 0.38
HPGD P15428 5/20 0.38
MAPT P10636 4/20 0.38
HTT P42858 3/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
TP53 P04637 2/20 0.38
HSD17B10 Q99714 2/20 0.38
ADORA1 P30542 2/20 0.38
NPSR1 Q6W5P4 3/20 0.35
POLB P06746 3/20 0.35
RAB9A P51151 1/20 0.35
SQOR Q9Y6N5 1/20 0.35
HRH4 Q9H3N8 2/20 0.35
ADORA2A P29274 2/20 0.34
ADRA2A P08913 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
PIM1 P11309 2/20 0.34
HIF1A Q16665 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6945144 0.90 HRH4 (0.40) KDM4EALDH1A1HPGDMAPTHTT
SCHEMBL6957443 0.90 KDM4E (0.36) KDM4EALDH1A1HPGDMAPTHTT
SCHEMBL6950700 0.89 PIK3CD (0.38) KDM4EALDH1A1HPGDMAPTHTT
SCHEMBL6947782 0.86 CXCR4 (0.41) KDM4EALDH1A1HPGDMAPTHTT
SCHEMBL6948613 0.83 KDM4C (0.40) KDM4EALDH1A1HPGDMAPTHTT
SCHEMBL6948239 0.80 PIK3CD (0.39) KDM4EALDH1A1HPGDMAPTHTT
SCHEMBL6955400 0.78 PIK3CD (0.38) KDM4EALDH1A1HPGDMAPTHTT
SCHEMBL6951221 0.78 SQOR (0.41) KDM4EALDH1A1HPGDMAPTHTT
SCHEMBL6945764 0.76 PIK3CD (0.37) KDM4EALDH1A1HPGDMAPTHTT
SCHEMBL6948352 0.76 ALDH1A1 (0.46) KDM4EALDH1A1HPGDMAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed